ICD-0-3 Implementation Guidelines for Cases Diagnosed 2024 Forward (Archived)
The ICD-0-3 Implementation Guidelines for cases diagnosed on or after January 1, 2024 have been posted on the NACCR and FCDS websites.
The ICD-O-3 Implementation Guidelines for cases diagnosed on or after January 1, 2024 are posted on the NACCR Website https://www.naaccr.org/icdo3/ and on the FCDS website under What is New. The majority of changes for 2024 are new related terms for existing codes, five new ICD-O codes, four reportable and one nonreportable, and one histology that has changed behavior and is now reportable. Please be sure to read the implementation guidelines before reviewing the tables below for more specific instructions.
TABLE 1: 2024 ICD-0-3.2 UPDATE (NUMERICAL ORDER)
Table 1 lists all changes for 2024 including five new ICD-O codes and terms, one code with changes to behavior, and new preferred or related terms, in numerical order by ICD-O number
Codes/terms listed numerically
Only new terminology to existing ICD-O-3.2 codes are included in the 2024 ICD-O Implementation guidelines and documentation. Terms are those listed in WHO Blue Books
Update based on 5th Ed Classification of Urinary and Male Genital Tumors
TABLE 2: 2024 ICD-0-3.2 UPDATE (ALPHABETIC ORDER)
Table 2 lists all changes for 2024 including five new ICD-O codes and terms, one code with changes to behavior, and new preferred or related terms, in alpha order by histology term.
Codes/terms listed alphabetically
Only new terminology to existing ICD-O-3.2 codes are included in the 2024 ICD-O Implementation guidelines and documentation. Terms are those listed in WHO Blue Books
Update based on 5th Ed Classification of Urinary and Male Genital Tumors
Can’t find what you are looking for? Click on the tags below to see related articles: